Many biologics, including blockbusters like Epogen/Procrit, are nearing patent expiration, and generics manufacturers, including Sicor (acquired by Teva), Barr Laboratories, and Ivax Corporation, are hoping to market generic biologics.
October 28, 2024
October 21, 2024
October 01, 2024
September 30, 2024
September 24, 2024
September 23, 2024
August 28, 2024